TMDXHealthcareMid-Cap

TransMedics Group, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for TransMedics Group, Inc. (TMDX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are TMDX insiders buying or selling?

TransMedics Group, Inc. insiders reported 6 open-market buys ($4.3M) and 190 sells ($176.3M) across 196 Form 4 filings — a net selling position of $172.1M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 17, 2026)

Total Form 4 filings
196
SEC EDGAR
Insider filers
18
Insider buys (6)
$4.3M
Insider sells (190)
$176.3M

Insider sentiment

Net selling

Net insider flow of $172.1M in net selling.

Recent TMDX insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 17, 2026Thomas J. GundersonDirectorSale9.6K$75.06$722.4K
Mar 6, 2026Stephanie LovellDirectorSale1.2K$149.62$178.5K
Mar 6, 2026David WeillDirectorSale3.6K$146.82$524.3K
Mar 5, 2026Gerardo HernandezChief Financial OfficerSale7.6K$146.81$1.1M
Mar 5, 2026Anil P. RanganathSenior Vice President, General Counsel and SecretarySale864$139.12$120.2K
Mar 5, 2026Nicholas CorcoranSVP of Supply Chain and OperationsSale3.0K$139.12$412.6K
Dec 5, 2025David WeillDirectorSale5.0K$138.64$693.2K
Dec 5, 2025Gerardo HernandezChief Financial OfficerSale920$139.62$128.5K
Nov 26, 2025Anil P. RanganathSenior Vice President, General Counsel and SecretarySale3.0K$145.22$435.7K
Nov 18, 2025Waleed H HassaneinPresident & CEOPurchase8.8K$114.00$1.0M
Oct 31, 2025Edward M BasileDirectorSale4.1K$130.45$540.3K
Aug 5, 2025Edward M BasileDirectorSale4.1K$125.51$520.0K
Jun 10, 2025Anil P. RanganathSenior Vice President, General Counsel and SecretarySale686$139.80$95.9K
May 29, 2025Edward M BasileDirectorSale5.0K$126.45$632.3K
May 23, 2025David WeillDirectorSale732$123.88$90.7K
May 13, 2025Edward M BasileDirectorSale6.0K$115.63$693.8K
Mar 5, 2025Tamer I KhayalChief Commercial OfficerSale2.4K$76.43$184.0K
Jan 10, 2025Tamer I KhayalChief Commercial OfficerSale1.1K$80.05$86.7K
Dec 4, 2024Tamer I KhayalChief Commercial OfficerSale1.1K$86.40$93.7K
Nov 13, 2024Tamer I KhayalChief Commercial OfficerSale1.5K$90.04$131.3K
Nov 7, 2024Edward M BasileDirectorSale6.8K$83.55$564.0K
Nov 5, 2024Tamer I KhayalChief Commercial OfficerSale1.1K$82.64$89.5K
Oct 17, 2024Waleed H HassaneinPresident & CEOSale8.6K$132.71$1.1M
Oct 3, 2024Tamer I KhayalChief Commercial OfficerSale3.0K$148.24$438.5K
Sep 17, 2024Waleed H HassaneinPresident & CEOSale8.6K$153.42$1.3M

Showing the 25 most recent of 196 Form 4 filings for TransMedics Group, Inc..

Most active TMDX insiders

  • Tamer I Khayal42 filings
  • Waleed H Hassanein35 filings
  • John F Carey33 filings
  • Stephen Gordon28 filings
  • Edward M Basile12 filings

Ask anything about TMDX insider activity

Use Trabud's AI agent to query TransMedics Group, Inc.'s Form 4 history in plain English — "Show me TMDX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

TMDX insider trading FAQ

Are TransMedics Group, Inc. insiders buying or selling?

Across 196 SEC Form 4 filings, TransMedics Group, Inc. (TMDX) insiders reported 6 open-market purchases totaling $4.3M and 190 sales totaling $176.3M. That is a net selling position of $172.1M.

How many insiders trade TMDX stock?

18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TransMedics Group, Inc.. The most recent filing was accepted on Jun 17, 2026.

Where does Trabud get TMDX insider trading data?

All TMDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content